Analysts sees a potential spinoff of FedEx’s freight business as a potential boost, but the stock is dropping sharply ...

Intuitive Machines is “the leading beneficiary of NASA’s lunar commercialization efforts,” says B. Riley Securities analyst ...

Investors poured $33.8 billion into U.S. stocks in the past week, with funds collecting the third-largest weekly haul since ...

Oil futures were on track for solid weekly gains, boosted by the Federal Reserve’s large rate cut and a renewed rise in ...

TOKYO — Shohei Ohtani’s feat of becoming the first major leaguer with at least 50 home runs and 50 stolen bases in a season ...

OTTAWA--Investments in productivity-enhancing artificial intelligence are boosting demand in the economy, and that could put upward pressure on inflation in the short term, Bank of Canada Gov. Tiff ...

Constellation Energy shares rose in premarket trading Friday after signing a deal to restart Pennsylvania's Three Mile Island nuclear plant to help power the Microsoft's growing artificial ...

The board of TransDigm Group has declared a special cash dividend of $75 per share. The supplier of highly engineered aircraft components said Friday that the board has also authorized cash dividend ...

Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer, was the key asset in AbbVie's $10.1 billion acquisition of biotech ImmunoGen that ...

General Motors has recalled nearly 450,000 vehicles equipped with indicators which don't promptly warn drivers when brake fluid levels are too low.

Merck & Co. said a European Medicines Agency panel recommended expanded approval of the drugmaker's blockbuster cancer treatment Keytruda in two types of gynecologic cancers.